239 related articles for article (PubMed ID: 37102660)
1. Manifestation of pityriasis rosea and pityriasis rosea-like eruptions after Covid-19 vaccine: A systematic review.
Khan I; Elsanousi AA; Shareef AM; Tebha SS; Arif A; Gul S
Immun Inflamm Dis; 2023 Apr; 11(4):e804. PubMed ID: 37102660
[TBL] [Abstract][Full Text] [Related]
2. Maculopapular eruptions following COVID-19 vaccination: Pityriasis rosea or pityriasis rosea-like eruptions?
Ciccarese G; Mastrolonardo M; Serviddio G; Drago F
J Cosmet Dermatol; 2023 Sep; 22(9):2380-2381. PubMed ID: 37382032
[No Abstract] [Full Text] [Related]
3. Pityriasis Rosea-like eruptions following COVID-19 mRNA-1273 vaccination: A case report and literature review.
Wang CS; Chen HH; Liu SH
J Formos Med Assoc; 2022 May; 121(5):1003-1007. PubMed ID: 35012825
[TBL] [Abstract][Full Text] [Related]
4. Pityriasis rosea, pityriasis rosea-like eruptions, and herpes zoster in the setting of COVID-19 and COVID-19 vaccination.
Drago F; Broccolo F; Ciccarese G
Clin Dermatol; 2022; 40(5):586-590. PubMed ID: 35093476
[TBL] [Abstract][Full Text] [Related]
5. Reply to "the significance of investigating clinical, histopathologic and virological features in pityriasis rosea and pityriasis rosea-like eruptions following COVID-19 vaccinations" by Ciccarese G. et al.
Martora F; Picone V; Battista T; Fabbrocini G; Marasca C
Dermatol Ther; 2022 Aug; 35(8):e15602. PubMed ID: 35622446
[No Abstract] [Full Text] [Related]
6. The significance of investigating clinical, histopathologic and virological features in pityriasis rosea and pityriasis rosea-like eruptions following COVID-19 vaccinations.
Ciccarese G; Parodi A; Drago F
Dermatol Ther; 2022 Aug; 35(8):e15601. PubMed ID: 35622411
[No Abstract] [Full Text] [Related]
7. Pityriasis Rosea Associated With COVID-19 Vaccination: A Common Rash Following Administration of a Novel Vaccine.
Valk B; Bender B
Cutis; 2021 Dec; 108(6):317-318. PubMed ID: 35167784
[TBL] [Abstract][Full Text] [Related]
8. Pityriasis Rosea after COVID-19 Infection.
Prtajin M; Ljubojević Hadžavdić S
Acta Dermatovenerol Croat; 2022 Dec; 30(4):265-266. PubMed ID: 36919396
[TBL] [Abstract][Full Text] [Related]
9. Cutaneous adverse reactions of COVID-19 vaccines: A systematic review.
Qaderi K; Golezar MH; Mardani A; Mallah MA; Moradi B; Kavoussi H; Shamsabadi A; Golezar S
Dermatol Ther; 2022 May; 35(5):e15391. PubMed ID: 35194894
[TBL] [Abstract][Full Text] [Related]
10. Pityriasis rosea like eruption: A dermatological manifestation of Coronavac-COVID-19 vaccine.
Gökçek GE; Öksüm Solak E; Çölgeçen E
Dermatol Ther; 2022 Feb; 35(2):e15256. PubMed ID: 34881483
[No Abstract] [Full Text] [Related]
11. Pityriasis rosea-like cutaneous eruption as a possible dermatological manifestation after Oxford-AstraZeneca vaccine: Case report and brief literature review.
Pedrazini MC; da Silva MH
Dermatol Ther; 2021 Nov; 34(6):e15129. PubMed ID: 34533265
[TBL] [Abstract][Full Text] [Related]
12. Pityriasis rosea following SARS-CoV-2 vaccination: A case series.
Temiz SA; Abdelmaksoud A; Dursun R; Durmaz K; Sadoughifar R; Hasan A
J Cosmet Dermatol; 2021 Oct; 20(10):3080-3084. PubMed ID: 34363731
[No Abstract] [Full Text] [Related]
13. Pityriasis Rosea Shortly After mRNA-1273 COVID-19 Vaccination.
Shin SH; Hong JK; Hong SA; Li K; Yoo KH
Int J Infect Dis; 2022 Jan; 114():88-89. PubMed ID: 34740803
[No Abstract] [Full Text] [Related]
14. Pityriasis Rosea Induced by COVID-19 Vaccination.
Khattab E; Christaki E; Pitsios C
Eur J Case Rep Intern Med; 2022; 9(2):003164. PubMed ID: 35265550
[TBL] [Abstract][Full Text] [Related]
15. Pityriasis rosea-like rash after messenger RNA COVID-19 vaccination: A case report and review of the literature.
Buckley JE; Landis LN; Rapini RP
JAAD Int; 2022 Jun; 7():164-168. PubMed ID: 35156062
[TBL] [Abstract][Full Text] [Related]
16. Six cases of pityriasis rosea following SARS-CoV-2 vaccination with BNT162b2.
Ramot Y; Nanova K; Faitatziadou SM; Assab DA; Berkun Y; Zlotogorski A
J Dtsch Dermatol Ges; 2022 Aug; 20(8):1123-1124. PubMed ID: 35698860
[No Abstract] [Full Text] [Related]
17. Pityriasis rosea-like eruptions following vaccination with BNT162b2 mRNA COVID-19 Vaccine.
Cyrenne BM; Al-Mohammedi F; DeKoven JG; Alhusayen R
J Eur Acad Dermatol Venereol; 2021 Sep; 35(9):e546-e548. PubMed ID: 33982814
[No Abstract] [Full Text] [Related]
18. Pityriasis rosea after mRNA COVID-19 vaccination.
Abdullah L; Hasbani D; Kurban M; Abbas O
Int J Dermatol; 2021 Sep; 60(9):1150-1151. PubMed ID: 34110010
[No Abstract] [Full Text] [Related]
19. Pityriasis rosea after administration of Pfizer-BioNTech COVID-19 vaccine.
Cohen OG; Clark AK; Milbar H; Tarlow M
Hum Vaccin Immunother; 2021 Nov; 17(11):4097-4098. PubMed ID: 34435935
[TBL] [Abstract][Full Text] [Related]
20. Vaccine-induced pityriasis rosea and pityriasis rosea-like eruptions: a review of the literature.
Drago F; Ciccarese G; Javor S; Parodi A
J Eur Acad Dermatol Venereol; 2016 Mar; 30(3):544-5. PubMed ID: 25545307
[No Abstract] [Full Text] [Related]
[Next] [New Search]
